Cargando…
SH3BGRL2 inhibits growth and metastasis in clear cell renal cell carcinoma via activating hippo/TEAD1-Twist1 pathway
BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is one of the most prevalent malignancies in the world, and tumor metastasis is still the main reason for disease progression. Accumulating evidence shows that SH3BGRL2 may play a key role in tumor progression and metastasis. However, the role of S...
Autores principales: | Yin, Lei, Li, Wenjia, Xu, Aiming, Shi, Heng, Wang, Keyi, Yang, Huan, Wang, Ronghao, Peng, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000347/ https://www.ncbi.nlm.nih.gov/pubmed/31911271 http://dx.doi.org/10.1016/j.ebiom.2019.12.005 |
Ejemplares similares
-
SH3BGRL2, a new downregulated tumor suppressor in clear cell renal cell carcinomas
por: Dufies, Maeva
Publicado: (2020) -
Dual-faced SH3BGRL: oncogenic in mice, tumor suppressive in humans
por: Wang, H, et al.
Publicado: (2016) -
SH3BGRL confers innate drug resistance in breast cancer by stabilizing HER2 activation on cell membrane
por: Li, Hui, et al.
Publicado: (2020) -
SH3BGRL Suppresses Liver Tumor Progression through Enhanced ATG5-Dependent Autophagy
por: Saleh, Abdulmomen Ali Mohammed, et al.
Publicado: (2023) -
SH3BGRL3 binds to myosin 1c in a calcium dependent manner and modulates migration in the MDA-MB-231 cell line
por: Di Pisa, Filippo, et al.
Publicado: (2021)